Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$4.19 - $13.97 $1.08 Million - $3.59 Million
-257,267 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$11.15 - $18.6 $1.73 Million - $2.88 Million
-155,000 Reduced 37.6%
257,267 $3.25 Million
Q2 2021

Aug 16, 2021

BUY
$15.4 - $31.46 $1.92 Million - $3.92 Million
124,542 Added 43.29%
412,267 $6.37 Million
Q1 2021

May 17, 2021

BUY
$25.86 - $39.93 $7.44 Million - $11.5 Million
287,725 New
287,725 $9.47 Million

Others Institutions Holding BOLT

About Bolt Biotherapeutics, Inc.


  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $19.2M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.